Abstract
HCC is the sixth most common cancer globally and the third leading cause of cancer-related death worldwide with a steadily increasing annual incidence of about 900,000 cases per year (1). HCC is the deadly complication of chronic liver disease and usually develops within liver cirrhosis related to different etiologies. In Asia and Africa hepatitis B virus (HBV) infection, with or without aflatoxin B1 exposure, is the most frequent etiology, whereas hepatitis C virus (HCV) infection, chronic alcohol abuse and metabolic syndrome are most frequently related to HCC in Western countries (1-4).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
